Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
18 studies found for:    "Hepatitis D, Chronic"
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.
Condition: Hepatitis D, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: placebo;   Drug: tenofovir
2 Completed
Has Results
A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Intervention: Drug: Pegylated Interferon (PEG-IFN) alfa-2a
3 Completed
Has Results
A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin
4 Terminated An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)
Condition: Hepatitis D, Chronic
Intervention:
5 Recruiting A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
Condition: Hepatitis D, Chronic
Intervention: Drug: Lambda
6 Not yet recruiting A Study of Lonafarnib With or Without Ritonavir in Patients With HDV
Condition: Chronic Delta Hepatitis
Interventions: Drug: Lonafarnib;   Drug: Ritonavir
7 Completed Titrating-Dose of Lonafarnib in Combination With Ritonavir
Condition: Chronic Delta Hepatitis
Interventions: Drug: lonafarnib;   Drug: Ritonavir
8 Recruiting A Long Term Follow-up Study of Patients From the REP 301 Protocol
Conditions: Hepatitis B, Chronic;   Hepatitis D, Chronic
Intervention:
9 Completed
Has Results
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)
Conditions: Hepatitis D, Chronic;   Hepatitis B, Chronic
Intervention: Biological: Peginterferon alfa-2b (PegIntron, SCH 54031)
10 Recruiting Lonafarnib With Ritonavir in HDV (LOWR-2)
Condition: Chronic Hepatitis D Infection
Interventions: Drug: lonafarnib;   Drug: Ritonavir;   Drug: PEG IFN-a
11 Completed Lonafarnib With and Without Ritonavir in HDV (LOWR-1)
Condition: Chronic Hepatitis D Infection
Interventions: Drug: lonafarnib;   Drug: PEG IFN-a;   Drug: Ritonavir
12 Recruiting Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Condition: Hepatitis D
Interventions: Drug: Lonafarnib;   Drug: Ritonavir;   Other: Placebo
13 Active, not recruiting Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With Chronic Hepatitis Delta
Condition: Chronic Hepatitis D Infection
Interventions: Drug: Myrcludex B;   Drug: pegINF
14 Active, not recruiting HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis
Condition: Hepatitis D
Interventions: Drug: PEG-IFN alfa-2a, Tenofovir;   Drug: PEG-IFN alfa-2a, placebo
15 Completed
Has Results
Lonafarnib for Chronic Hepatitis D
Condition: Hepatitis D
Interventions: Drug: Lonafarnib;   Other: Placebo
16 Completed
Has Results
Pegylated Interferon to Treat Chronic Hepatitis D
Condition: Hepatitis D
Intervention: Drug: Peginterferon Alpha-2a
17 Unknown  Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D
Intervention: Drug: pegylated IFN alfa-2b plus ribavirin
18 Completed Lamivudine for Chronic Hepatitis B
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D;   Glomerulonephritis;   Polyarteritis Nodosa
Intervention: Drug: Lamivudine

Study has passed its completion date and status has not been verified in more than two years.